Ensign Peak Advisors’s Ocular Therapeutix OCUL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2022
Q3 | – | Sell |
-29,050
| Closed | -$117K | – | 2341 |
|
|
2022
Q2 | $117K | Hold |
29,050
| – | – | ﹤0.01% | 1931 |
|
|
2022
Q1 | $144K | Buy |
29,050
+14,020
| +93% | +$69.5K | ﹤0.01% | 1959 |
|
|
2021
Q4 | $105K | Buy |
15,030
+9,030
| +151% | +$63.1K | ﹤0.01% | 2050 |
|
|
2021
Q3 | $60K | Hold |
6,000
| – | – | ﹤0.01% | 1824 |
|
|
2021
Q2 | $85K | Sell |
6,000
-53,711
| -90% | -$761K | ﹤0.01% | 1791 |
|
|
2021
Q1 | $979K | Buy |
59,711
+39,711
| +199% | +$651K | ﹤0.01% | 1432 |
|
|
2020
Q4 | $414K | Buy |
+20,000
| New | +$414K | ﹤0.01% | 1636 |
|